Why Henry Schein (HSIC) Stock Is Up Today

What Happened?

Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) jumped 2.8% in the afternoon session after Barclays initiated coverage on the company with an 'Overweight' rating and an $86 price target. The rating from the bank reflected a positive outlook on the company's potential for growth. Analyst Glen Santangelo announced the new coverage. Adding to the positive sentiment, Henry Schein also announced an extension of its strategic partnership with KKR. As part of the agreement, KKR's designees, Max Lin and William K. “Dan” Daniel, were set to be renominated for election to the company's board of directors at the 2026 Annual Meeting.

The shares closed the day at $74.42, up 2.1% from previous close.

Is now the time to buy Henry Schein? Access our full analysis report here.

What Is The Market Telling Us

Henry Schein’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.

The previous big move we wrote about was 18 days ago when the stock gained 3.7% on the news that comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.

Henry Schein is up 8.6% since the beginning of the year, but at $74.44 per share, it is still trading 9.1% below its 52-week high of $81.91 from February 2025. Investors who bought $1,000 worth of Henry Schein’s shares 5 years ago would now be looking at an investment worth $1,046.

While Wall Street chases Nvidia at all-time highs, an under-the-radar semiconductor supplier is dominating a critical AI component these giants can’t build without. Click here to access our full research report.